Biotech

Agile Therapeutics Recognized as the 2011 Life Sciences Company of the Year by the New Jersey Technology Council

PRINCETON, NJ: Agile's First Product Nears Completion of Phase 3 Clinical Trials ...

Paladin Reports Second Quarter 2011 Financial Results: Achieves Record Quarterly Revenues and EBITDA

MONTREAL, CANADA: ...

Ondine Biomedical Announces 2011 Second Quarter Financial Results

VANCOUVER, BRITISH COLUMBIA: ...

Marina Biotech Demonstrates In Vivo Knockdown of a microRNA With a CRN-Modified Antagomir

BOTHELL, WA: Results Show That a Single-Stranded Oligonucleotide Construct, Modified With the Company's Proprietary Conformationally Restricted Nucleotide (CRN) Technology, Demonstrated High Potency and Good ...

Paladin Labs Announces Premium Offer to Acquire Afexa Life Sciences for $0.55 per Share

MONTREAL, QUEBEC: - 57% premium to recent share price - Choice of $0.55 in cash or 0.013 of a Paladin share per Afexa share - Offer for any and all Afexa shares - Minimal and customary conditions ...

ProMetic to Hold Second Quarter 2011 Financial Results Conference Call and Webcast

MONTREAL, QUEBEC, CANADA: ...

Second Genome Announces Series A Financing

SAN FRANCISCO, CA: ATV, Morgenthaler Co-Lead Investment in Company Leveraging the Microbiome for Personalized Medicine Solutions ...

Alethia Biotherapeutics Announces Issuance of its Second Therapeutic Target Patent Stemming From its Proprietary Target Discovery Platform

MONTREAL, QUEBEC: ...

Titan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2011 Financial Results and Probuphine Phase 3 Clinical Study Results

SOUTH SAN FRANCISCO, CA: Leading Addiction Medicine Experts to Join Company for Call ...

Corcept Therapeutics Announces Second Quarter Results and Corporate and Development Update

MENLO PARK, CA: ...